Free Newsletter
Register for our Free Newsletters
Analysis, Inspection and Laboratory
Assisted/Independent Living
Clinical and Nursing Equipment
Design and Manufacture of Medical Equipment
Diagnostics Equipment, Monitoring and Test
Education, Training and Professional Services
Health Education and Patient Management
Health Estates Management
Healthcare Support and Information Services
Hygiene and Infection Control
IT and Communications in Healthcare
Medical Device Technology
Research and Development
Safety and Security
View All
Other Carouselweb publications
Carousel Web
Defense File
New Materials
Pro Health Zone
Pro Health Zone
Pro Security Zone
Web Lec
Pro Engineering Zone

Avista agrees to acquire Bristol-Myers Squibb Medical Imaging business

Bristol-Myers Squibb : 17 December, 2007  (New Product)
Bristol-Myers Squibb and Avista Capital Partners, a leading private equity firm, have signed a definitive agreement for Avista to acquire Bristol-Myers Squibb Medical Imaging (BMS MI), a leading supplier of medical imaging products for nuclear and ultrasound cardiovascular diagnostic imaging procedures, for approximately $525 million of cash proceeds.
BMS MI a business unit of Bristol-Myers Squibb.

'As Bristol-Myers Squibb continues to focus on evolving into a next- generation BioPharma company, we determined the best way to maximise the value of Medical Imaging for shareholders was to sell this business and reinvest the proceeds into our pharmaceutical research, development and commercialisation efforts,' said James M Cornelius, chief executive officer, Bristol-Myers Squibb. 'At the same time, we believe that Medical Imaging can maximise its potential under new ownership, and Avista has a proven track record of success in the healthcare field.'

David Burgstahler, a partner at Avista Capital Partners, said, 'Bristol- Myers Squibb Medical Imaging is widely recognised as a pioneer in cardiovascular imaging agents, and for its strong technical manufacturing expertise. BMS MI is a great fit for our healthcare portfolio, as it addresses the healthcare industry's increasing need for improved diagnostic tools. We believe it is well-positioned for continued success.'

The transaction is expected to be completed by the end of January 2008, subject to customary regulatory approvals, at which time BMS MI will operate as an independent company under a new name. Don Kiepert, the founder and former chairman, CEO, and president of Point Therapeutics, will become the chief executive officer of the company upon completion of the transaction. 'I am thrilled to be partnering with the existing management team of BMS MI and Avista Capital as we transition BMS MI to an independent company,' said Kiepert.

'BMS MI has exceptional brands, a cutting-edge research and development facility, and a knowledgeable sales force. It is a great fit for our healthcare portfolio, as it addresses the healthcare industry's increasing need for improved diagnostic tools,' said Larry Pickering, Avista Capital Partners' healthcare industry partner. 'We believe that BMS MI is well- positioned for continued success and Don Kiepert is the right leader to optimise the growth opportunities within BMS MI's pipeline.'

Tim Ravenscroft, president of BMS MI said, 'The Avista team is committed to long-term growth, and as the new owner of the business, will renew our focus on developing and expanding our business.'

Bristol-Myers Squibb Medical Imaging will be Avista's sixth investment in the healthcare industry. On December 13, 2007, Avista agreed to acquire from Boston Scientific its Fluid Management and Venous Access businesses.

Also in 2007, Avista made healthcare investments in BioReliance and VWR International, and in 2006 Avista announced investments in Nycomed and MedServe. While at DLJ Merchant Banking Partners, the Avista partners were involved in numerous healthcare transactions including Accellent, Charles River Laboratories, Focus Diagnostics, KCI, NextPharma, Prometheus Labs, and Warner Chilcott.
Bookmark and Share
Home I Editor's Blog I News by Zone I News by Date I News by Category I Special Reports I Directory I Events I Advertise I Submit Your News I About Us I Guides
   © 2012
Netgains Logo